Chloral hydrate
- Generic Name
- Chloral hydrate
- Brand Names
- Nortec
- Drug Type
- Small Molecule
- Chemical Formula
- C2H3Cl3O2
- CAS Number
- 302-17-0
- Unique Ingredient Identifier
- 418M5916WG
- Background
A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication.
- Indication
Mainly used as a hypnotic in the treatment of insomnia; however, it is only effective as a hypnotic for short-term use. May be used as a routine sedative preoperatively to decrease anxiety and cause sedation and/or sleep with respiration depression or cough reflex.
- Associated Conditions
- Alcohol Withdrawal Syndrome, Opioid Withdrawal (Disorder), Postoperative pain, Barbiturate withdrawal
- Associated Therapies
- Sedative therapy
Chloral Hydrate to Perform Auditory Brainstem Response (ABR)
- Conditions
- Interventions
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2009-07-31
- Lead Sponsor
- Pontificia Universidade Catolica de Sao Paulo
- Target Recruit Count
- 41
- Registration Number
- NCT00949780
- Locations
- 🇧🇷
Derdic-Pucsp, São Paulo, Brazil
🇧🇷Mariana Lopes Favero, São Paulo, Brazil
Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG
- Conditions
- Interventions
- First Posted Date
- 2007-04-23
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Wesley Medical Center
- Registration Number
- NCT00464451
- Locations
- 🇺🇸
Pediatric Sedation Unit, Wesley Medical Center, Wichita, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.